We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

DaVita Inc (DVA) Common Stock USD0.001

Sell:$143.71 Buy:$143.76 Change: $1.32 (0.93%)
Market closed |  Prices as at close on 24 July 2024 | Switch to live prices |
Change: $1.32 (0.93%)
Market closed |  Prices as at close on 24 July 2024 | Switch to live prices |
Change: $1.32 (0.93%)
Market closed |  Prices as at close on 24 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Contact details

2000 16th St
United States
+1 (310) 5362668

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$12.27 billion
Shares in issue:
87.70 million
Health Care Services
New York Stock Exchange
United States
US dollar

Key personnel

  • Javier Rodriguez
    Chief Executive Officer, Director
  • Joel Ackerman
    Chief Financial Officer, Treasurer
  • Christopher Berry
    Chief Accounting Officer
  • Madhu Narasimhan
    Chief Information Officer
  • James Hearty
    Chief Compliance Officer
  • Michael Staffieri
    Chief Operating Officer - DaVita Kidney Care
  • Kathleen Waters
    Chief Legal and Public Affairs Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.